Filter Results:
(661)
Show Results For
- All HBS Web
(661)
- People (2)
- News (222)
- Research (299)
- Events (4)
- Multimedia (12)
- Faculty Publications (184)
Show Results For
- All HBS Web
(661)
- People (2)
- News (222)
- Research (299)
- Events (4)
- Multimedia (12)
- Faculty Publications (184)
- Video
Anand Burman
Anand Burman, Chairman of Dabur, one of India’s largest manufacturers of natural medicine and consumer products, explains how his company overcame shortages of fresh herbs and plants by establishing nursery greenhouses in India and Nepal. View Details
- March 2024
- Article
Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act
By: Matthew Vogel, Pragya Kakani, Amitabh Chandra and Rena M. Conti
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using historical data from public and proprietary sources to apply the IRA's negotiation criteria retrospectively, we identify all drugs that... View Details
Keywords: Policy; Government Legislation; Health Care and Treatment; Negotiation; Price; Pharmaceutical Industry
Vogel, Matthew, Pragya Kakani, Amitabh Chandra, and Rena M. Conti. "Medicare Price Negotiation and Pharmaceutical Innovation Following the Inflation Reduction Act." Nature Biotechnology 42, no. 3 (March 2024): 406–412.
- 06 Jun 2018
- Video
Tarran Pierfelice, Blavatnik Fellow 2018-2019
Roche: Innovation and Access to Healthcare
Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that had access... View Details
- 20 Feb 2018
- News
EHRs fall short in reducing administrative costs
- June 2016
- Article
When Doctors Go to Business School: Career Choices of Physician-MBAs
By: Damir Ljuboja, Brian W. Powers, Benjamin Robbins, Robert S. Huckman, Krishna Yeshwant and Sachin Jain
There has been substantial growth in the number of physicians pursuing Master of Business Administration (MBA) degrees over the past decade, but there is continuing debate over the utility of these programs and the career outcomes of their graduates. The authors... View Details
Keywords: Medical Education; MD; MBA; Physicians; Executive Education; Training; Personal Development and Career; Health Care and Treatment; Health Industry; United States
Ljuboja, Damir, Brian W. Powers, Benjamin Robbins, Robert S. Huckman, Krishna Yeshwant, and Sachin Jain. "When Doctors Go to Business School: Career Choices of Physician-MBAs." American Journal of Managed Care 22, no. 6 (June 2016): e196–e198.
- 15 May 2011
- News
Deeply conflicted
- 11 Jan 2017
- News
How do we solve the crisis in cancer communication?
- 21 Jun 2018
- Video
KPMA HBX Live: Cracking the Data Aggregation Problem - Paul Giusti
- 25 Feb 2019
- News
Impact investing: a new way to fund cures for cancer
- 25 Aug 2015
- Blog Post
Why an MD/MBA from HBS and HMS?
It is not uncommon for me to be asked, "So, what do you want to do when you grow up?” In response, I usually respond, "I want to change health care." Anyone who knows me will understand my penchant for exaggeration, but there is still some truth to my... View Details
- July 2002 (Revised August 2002)
- Case
Washington Hospital Center (B): The Power of Insight
By: Rosabeth M. Kanter and Michelle Heskett
Dr. Craig Feied considers how to take a major technical innovation beyond his own department into a large hospital system. Reviews how proprietary information systems became indispensable in the department of emergency medicine and what it took to introduce the change... View Details
- June 2023 (Revised June 2023)
- Supplement
Roche: ESG and Access to Healthcare
By: George Serafeim
In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that had... View Details
Keywords: ESG (Environmental, Social, Governance) Performance; Sustainable Finance; Growth Strategy And Execution; Sustainability Targets; Impact Evaluation; Healthcare Access; Healthcare Innovation; Healthcare Systems; Healthcare Operations; Finance; Strategy; Health Testing and Trials; Health Care and Treatment; Growth Management; Measurement and Metrics; Innovation Strategy; Corporate Social Responsibility and Impact; Health Industry; Pharmaceutical Industry; Switzerland; North America; Europe; Asia; Latin America; Africa
Serafeim, George. "Roche: Innovation and Access to Healthcare." Harvard Business School Multimedia/Video Supplement 123-713, June 2023. (Revised June 2023.)
- 14 Jul 2020
- News
A New Playbook for Cure-Seeking Nonprofits
- February 1993 (Revised March 1995)
- Case
Bernd Sterzel at the IVth Medizinische Klinik (A)
By: Linda A. Hill
After 10 years of running a small laboratory at Yale Medical School, Dr. R. Bernd Sterzel assumes leadership of a nephrology clinic in Nurnberg and Erlangen, Germany. In his ambitious efforts to transform the clinic into a leading academic research institution, he... View Details
Keywords: Change Management; Organizational Change and Adaptation; Problems and Challenges; Cross-Cultural and Cross-Border Issues; Health Industry; Germany; Connecticut
Hill, Linda A. "Bernd Sterzel at the IVth Medizinische Klinik (A)." Harvard Business School Case 493-059, February 1993. (Revised March 1995.)
- 21 Jun 2018
- Video